Nasal Sleep Formulation with Crystalline CBD
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for insomnia and sleep disorders are inadequate, as they often rely on conventional medications that may have side effects and do not effectively address the underlying issues, and there is a need for alternative compositions that can provide relief for a range of conditions including Parkinson's, multiple sclerosis, muscle spasms, anxiety, depression, and neuroprotective effects.
Innovation Solution
A composition comprising 5-30% hemp oil, 0.1-5.0% cannabidiol (CBD) and/or cannabinol (CBN), 0.01-1.0% lavender oil, and 30-95% sesame oil, with optional vitamin E, formulated as a nasal spray for intranasal application, which also includes crystalline CBD for enhanced potency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional medications are used to treat sleep disorders, then sleep disorders can be treated, but side effects occur and underlying issues are not effectively addressed
Solution Approach 1:
The patent changes the chemical parameters by using specific cannabinoid combinations (CBD, CBN, THC in controlled ratios) and oil bases (hemp oil, sesame oil, lavender oil) to achieve effective sleep disorder treatment without the harmful side effects of conventional medications. The formulation parameters including concentration ranges and oil types are optimized for safety and effectiveness.
Solution Approach 2:
The invention uses composite material formulation combining multiple cannabinoids (CBD, CBN, and controlled amounts of THC) with specific oil bases (hemp oil, sesame oil, lavender oil) to create a synergistic treatment that addresses sleep disorders effectively while minimizing side effects through the combined properties of these natural components.
2Reliability
If crystalline CBD is used in the composition, then potency is significantly increased, but manufacturing complexity increases
Solution Approach 1:
The patent specifies that CBD should be in crystalline form (needle-like crystals) to achieve enhanced potency, while providing specific concentration ranges (0.1-5.0%) that balance effectiveness with manufacturability. This parameter specification guides the manufacturing process to produce the desired crystalline structure without excessive complexity.
Solution Approach 2:
The invention accepts that crystalline CBD requires more sophisticated manufacturing but justifies this through the significant potency enhancement and therapeutic effectiveness, implying that the increased manufacturing complexity is warranted by the superior performance and potential to replace conventional medications.
Data Source
AI summary
A composition for treatment of sleep disorders is disclosed, said composition comprising by weight: 5-30% hemp oil: 0.1-5.0% cannabidiol (CBD) and/or cannabinol (CBN): 0.01-1.0% lavender oil: 30-95% (or up to 100%) sesame oil: and 0.1-5.0% vitamin E and/or Tocopherol equivalents. Such a composition can e.g. be administered intra-nasally, such as by the use of a nasal spray bottle.